Source: iQoncept / Shutterstock
Lantern Pharma (NASDAQ:LTRN) has released its financial performance for the fourth quarter of 2023.
- Exceeding expectations, Lantern Pharma posted earnings per share of -39 cents, surpassing the anticipated -40 cents.
- The quarter, however, did not witness any revenue generation by the company.
InvestorPlace Earnings introduces a revolutionary means of presenting data from TradeSmith to automate the coverage of quarterly earnings reports. This innovation distills crucial information like earnings per share and revenue, shedding light on how a company compares to analyst forecasts. These write-ups are generated without human intervention, enabling us to promptly enlighten our audience about the latest financial standings. For any feedback or corrections, please reach out to us at [email protected].
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/ltrn-stock-earnings-lantern-pharma-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
